STOCK TITAN

MapLight Therapeutics: Forbion reports roughly 8.4% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

MapLight Therapeutics, Inc. (MPLT) is the subject of an amended beneficial-ownership report in which Forbion Growth Opportunities Fund III Cooperatief U.A. reports directly owning 4,428,328 voting common shares. Forbion Growth III Management B.V., as director of the fund, may be deemed to have voting and investment power over those same shares.

Both reporting persons report shared voting and dispositive power over 4,428,328 shares, representing approximately 8.4% of the outstanding voting common stock. The percentage is based on 52,848,208 shares outstanding, as reported in MapLight’s prospectus filed September 23, 2026.

Shares beneficially owned 4,428,328 shares Reported by each reporting person; the fund directly owns the shares.
Percentage of outstanding voting common stock Approximately 8.4% Reported by each reporting person.
Voting common stock outstanding 52,848,208 shares Reported in MapLight’s prospectus filed September 23, 2026; used as the basis for the reported percentage.
investment power regulatory
"may be deemed to have voting and investment power"
shared voting power regulatory
"Shared voting power 4,428,328"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power 4,428,328"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MPLT shares do the Forbion Growth III entities report?

Forbion Growth Opportunities Fund III Cooperatief U.A. directly owns 4,428,328 shares, and Forbion Growth III Management B.V. may be deemed to have voting and investment power over those same shares as the fund’s director.

What percentage of MPLT does Forbion report owning?

The reporting persons report approximately 8.4% of MapLight’s outstanding voting common stock, based on 52,848,208 shares outstanding as reported in the issuer’s prospectus filed September 23, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





56565P103

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Forbion Growth Opportunities Fund III Cooperatief U.A.
Signature:/s/ G.J Mulder and /s/ M.A. van Osch
Name/Title:Directors of its Director
Date:11/16/2026
Forbion Growth III Management B.V.
Signature:/s/ G.J Mulder and /s/ M.A. van Osch
Name/Title:Directors
Date:11/16/2026

Keep reading